While prognoses for prostate cancer patients were once measured in months, experts say that advances in treatment and diagnosis now improve survival by years.

Dr. David B. Samadi questioned how Biden’s doctors could know this unless the 82-year-old was already undergoing cancer treatment.

The announcement Sunday that former President Joe Biden was diagnosed with advanced prostate cancer has some people wondering how the disease could have been missed.

The FDA has approved 21 mg leuprolide mesylate (Camcevi ETM, Foresee Pharmaceuticals) as a ready-to-use long-acting injectable emulsion to be administered every 3 months for the treatment of advanced ...

Biden’s cancer renews debate about prostate screenings for older men It is not unusual for a man of Biden’s age to skip prostate cancer screening, for a variety of reasons.